KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Shares Issued (2016 - 2023)

TherapeuticsMD (TXMD) has disclosed Shares Issued for 12 consecutive years, with $2.0 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Shares Issued fell 17.95% year-over-year to $2.0 million, compared with a TTM value of $188.3 million through Dec 2023, up 427.97%, and an annual FY2023 reading of $3.2 million, up 28.4% over the prior year.
  • Shares Issued was $2.0 million for Q4 2023 at TherapeuticsMD, up from -$1000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $183.8 million in Q4 2021 and bottomed at -$150.6 million in Q2 2021.
  • Average Shares Issued over 5 years is $21.2 million, with a median of $103053.5 recorded in 2019.
  • Peak annual rise in Shares Issued hit 209481.94% in 2021, while the deepest fall reached 160312.77% in 2021.
  • Year by year, Shares Issued stood at $76.9 million in 2019, then tumbled by 59.14% to $31.4 million in 2020, then skyrocketed by 484.81% to $183.8 million in 2021, then tumbled by 98.67% to $2.4 million in 2022, then dropped by 17.95% to $2.0 million in 2023.
  • Business Quant data shows Shares Issued for TXMD at $2.0 million in Q4 2023, -$1000.0 in Q3 2023, and $2.4 million in Q4 2022.